Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Global consortium aims to protect babies from their first week of life

Babies are most vulnerable to life-threatening diseases in their first few weeks of life, yet current vaccines can’t be given until two months of age.

Animals in Research

We unite experts and communities to improve child health through research that has impact, using animals only when no other methods are suitable. We are also a signatory to the ANZCCART Animals in Research Openness Agreement.

Expertise and technologies

The Kids has a range of specialised expertise, tools, platforms and technology to undertake cutting-edge science.

Deadly bug in researchers’ sight at The Kids

The Institute has become one of the world’s leading Strep A hubs, with multiple teams working in the Institute’s END RHD Program, headed by Associate Professor Asha Bowen, working to understand how Strep A works and find better ways to prevent and control the diseases it causes.

Gold standard treatment for all diabetes patients

Imagine you had a healthy daughter one day and the next being told she has an incurable condition that requires day-to-day care and insulin treatment to stay alive.

Research

PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life

Nasopharyngeal colonisation with nontypeable Haemophilus influenzae (NTHi) is associated with development of infections including pneumonia and otitis media. The 10-valent pneumococcal conjugate vaccine (PCV10) uses NTHi Protein D (PD) as a carrier. Papua New Guinean children have exceptionally early and dense NTHi carriage, and high rates of NTHi-associated disease.